Prevalence of Bronchiolitis Obliterans Syndrome (BOS) [clinicaltrials_resource:NCT01009619/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Prevalence of Bronchiolitis Obliterans Syndrome (BOS) [clinicaltrials_resource:NCT01009619/outcome/1]
Bio2RDF identifier
NCT01009619/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT01009619/outcome/1
analysis [clinicaltrials_vocabulary:analysis]
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
intention to treat analysis
intention to treat
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
2 years post-transplant
during first two years post-transplant
during the first two years post-transplant
type [clinicaltrials_vocabulary:type]
alternate
Prevalence of Bronchiolitis Obliterans Syndrome (BOS)
@en
identifier
clinicaltrials_resource:NCT01009619/outcome/1
title
BOS was defined as a sustained ...... n the absence of other causes.
@en
type
label
Prevalence of Bronchiolitis Ob ...... esource:NCT01009619/outcome/1]
@en